UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

Endocrinology (Philadelphia), 2003-03, Vol.144 (3), p.1032-1044

2003

Volltextzugriff (PDF)

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2018-08, Vol.20 (1), p.98-98, Article 98

2018

Volltextzugriff (PDF)

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

Breast cancer research : BCR, 2011-03, Vol.13 (2), p.R29-R29, Article R29

2011

Volltextzugriff (PDF)

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

Breast cancer research : BCR, 2011-09, Vol.13 (5), p.R93-R93, Article R93

2011

Volltextzugriff (PDF)

Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance

Breast cancer research and treatment, 2008-09, Vol.111 (1), p.79-91

2008

Volltextzugriff (PDF)

Growth factor receptor interplay and resistance in cancer

Endocrine-related cancer, 2006-12, Vol.13 (Supplement_1), p.S45-S51

2006

Volltextzugriff (PDF)

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2007-08, Vol.9 (4), p.R50-R50, Article R50

2007

Volltextzugriff (PDF)

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells

Breast cancer research and treatment, 2003-09, Vol.81 (1), p.81-93

2003

Volltextzugriff (PDF)

Nonendocrine pathways and endocrine resistance: Observations with antiestrogens and signal transduction inhibitors in combination

Clinical cancer research, 2004-01, Vol.10 (1), p.346s-354s

2004

Volltextzugriff (PDF)

ADAM metalloproteases and EGFR signalling

Breast cancer research : BCR, 2003-01, Vol.5 (5), p.223-224, Article 223

2003

Volltextzugriff (PDF)

Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy

Endocrine-related cancer, 2006-12, Vol.13 (Supplement_1), p.S89-S97

2006

Volltextzugriff (PDF)

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer

International journal of cancer, 2004-03, Vol.108 (6), p.930-936

2004

Volltextzugriff (PDF)

The biology of antihormone failure in breast cancer

Breast cancer research and treatment, 2003-01, Vol.80 Suppl 1 (S1), p.S29-34

2003

Volltextzugriff (PDF)

The role of the glucocorticoid receptor in anti-hormone resistance in breast cancer

The British student doctor journal, 2021-01, Vol.5 (1), p.18

2021

Volltextzugriff (PDF)

Abstract LB-113: Antihormone-induced expression of BCL3 in estrogen receptor-positive breast cancer drives resistant cell growth

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.LB-113-LB-113

2016

Volltextzugriff (PDF)

Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance

Hormone molecular biology and clinical investigation, 2011-03, Vol.5 (2), p.67-77

2011

Volltextzugriff (PDF)

Correction to: Heregulin [beta]1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2018-08, Vol.20 (1)

2018

Volltextzugriff (PDF)

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)

Endocrinology (Philadelphia), 2001-07, Vol.142 (7), p.2776-2788

2001

Volltextzugriff (PDF)

Nonendocrine Pathways and Endocrine Resistance

Clinical cancer research, 2004-01, Vol.10 (1), p.346s-354s

2004

Volltextzugriff (PDF)

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin [beta]1

Breast cancer research : BCR, 2011-03, Vol.13, p.R29

2011

Volltextzugriff (PDF)

A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer

International journal of cancer, 2000-03, Vol.89 (2), p.209-212

2000

Volltextzugriff (PDF)

Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro

Journal of the American Society of Nephrology, 1998-09, Vol.9 (9), p.1629-1637

1998

Volltextzugriff (PDF)

BRCA1 expression levels predict distant metastasis of sporadic breast cancers

International journal of cancer, 1999-06, Vol.84 (3), p.258-262

1999

Volltextzugriff (PDF)

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Breast cancer research : BCR, 2007, Vol.9 (4), p.R50-R50

2007

Volltextzugriff (PDF)

Identification and independent regulation of human mesangial cell metalloproteinases

Kidney international, 1994-09, Vol.46 (3), p.877-885

1994

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1

erbB3 recruitment of insulin receptor substrate 1 modulates insulin-like growth factor receptor signalling in oestrogen receptor-positive breast cancer cell lines

Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib (‘Iressa’) response and resistance

Growth factor receptor interplay and resistance in cancer

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells

Nonendocrine pathways and endocrine resistance: Observations with antiestrogens and signal transduction inhibitors in combination

ADAM metalloproteases and EGFR signalling

Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer

The biology of antihormone failure in breast cancer

The role of the glucocorticoid receptor in anti-hormone resistance in breast cancer

Abstract LB-113: Antihormone-induced expression of BCL3 in estrogen receptor-positive breast cancer drives resistant cell growth

Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance

Correction to: Heregulin [beta]1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Enhanced Epidermal Growth Factor Receptor Signaling in MCF7 Breast Cancer Cells after Long-Term Culture in the Presence of the Pure Antiestrogen ICI 182,780 (Faslodex)

Nonendocrine Pathways and Endocrine Resistance

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin [beta]1

A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer

Differential regulation of matrix metalloproteinases and their inhibitors in human glomerular epithelial cells in vitro

BRCA1 expression levels predict distant metastasis of sporadic breast cancers

Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Identification and independent regulation of human mesangial cell metalloproteinases

Suchergebnisse filtern